Myeloma Combo With 'Unprecedented' Effect Wins FDA Approval

(MedPage Today) — A promising combination for multiple myeloma received FDA approval as a second-line therapy.
The approval of teclistamab (Tecvayli) plus daratumumab hyaluronidase (Darzalex Faspro) stipulates use in patients who have received…

Source link : https://www.medpagetoday.com/hematologyoncology/myeloma/120201

Author :

Publish date : 2026-03-06 18:43:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Myeloma Combo With ‘Unprecedented’ Effect Wins FDA Approval

How Springing Forward to Daylight Saving Time Can Affect Health

NASA changed an asteroid’s orbit around the sun for the first time

Related Posts

Hantavirus Risk to US Public Remains Low, CDC Says

GLP-1s and Hepatic Events; ‘Shame, Taboo, Hygiene’; Treating Late-Onset IBD

Nurse Killed in Hospital Parking Lot; Deadly Cosmetic Surgery Suit; EHR Lawsuit

Vocal fry is more common in men, actually, find scientists

Oncologist Who Cared for Hantavirus Patients on Ship Leaves Medical Isolation Unit

De-Escalated Treatment for Early Breast Cancer Continues to Gain Momentum

Hantavirus Risk to US Public Remains Low, CDC Says

GLP-1s and Hepatic Events; ‘Shame, Taboo, Hygiene’; Treating Late-Onset IBD

Nurse Killed in Hospital Parking Lot; Deadly Cosmetic Surgery Suit; EHR Lawsuit

Oncologist Who Cared for Hantavirus Patients on Ship Leaves Medical Isolation Unit

De-Escalated Treatment for Early Breast Cancer Continues to Gain Momentum

Two New Physician Social Media Platforms Come Online

Will burying dead trees after a wildfire keep their carbon locked up?

On the Horizon: Dry Eye in Focus at ARVO 2026

Categories

Archives